June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Effects of Metformin Treatment on Retinal Blood Flow in Diabetic Mice
Author Affiliations & Notes
  • Joy Zhang
    Ophthalmology, Henry Ford Health System, Bloomfield, Michigan, United States
  • Yue Li
    Ophthalmology, Henry Ford Health System, Bloomfield, Michigan, United States
  • Tongrong Zhou
    Ophthalmology, Henry Ford Health System, Bloomfield, Michigan, United States
  • Paul A Edwards
    Ophthalmology, Henry Ford Health System, Bloomfield, Michigan, United States
  • Hua Gao
    Ophthalmology, Henry Ford Health System, Bloomfield, Michigan, United States
  • Xiaoxi Qiao
    Ophthalmology, Henry Ford Health System, Bloomfield, Michigan, United States
  • Footnotes
    Commercial Relationships   Joy Zhang, None; Yue Li, None; Tongrong Zhou, None; Paul Edwards, None; Hua Gao, None; Xiaoxi Qiao, None
  • Footnotes
    Support  Alliance for Vision Research Award
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 78. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Joy Zhang, Yue Li, Tongrong Zhou, Paul A Edwards, Hua Gao, Xiaoxi Qiao; Effects of Metformin Treatment on Retinal Blood Flow in Diabetic Mice. Invest. Ophthalmol. Vis. Sci. 2017;58(8):78.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Metabolic alterations in diabetes can affect retinal blood flow. In this study, we qualitatively assess the effect of metformin treatment on retinal blood flow in a diabetic mouse model.

Methods : Diabetes was induced in young adult C57BL/6 mice by intraperitoneal injection of streptozotocin (STZ) in 5 consecutive days. Metformin hydrochloride oral solution was given to the mice by gavage at 200 mg/kg/d after STZ injection for 10 weeks. The retinal vasculature was evaluated by fluorescent angiography (FA) at 6 and 10 weeks in wild-type, STZ-induced diabetic, and metformin-treated STZ diabetic mice. FA videos were recorded using a Micron III retinal imaging microscope and analyzed using ImageJ and MATLAB.

Results : There were no notable abnormal changes in all mice on Fundus examination. FA revealed no visible retinal vascular leakage in any mice. In pixel-by-pixel analysis of FA videos, the ratio of pixels that corresponds to early perfusion was similar among the three groups. A smooth and moderate increase of pixel ratio that represents late-stage perfusion was seen in wild type mice. In contrast, the ratio of late-stage pixels in STZ diabetic mice was almost doubled when compared with wild type controls, indicating a significantly delayed and prolonged retinal circulation time at late stage in these diabetic mice. With metformin treatment, a lower ratio of late-stage pixels was observed in the diabetic mice, suggesting a potentially partial protective effect on late stage perfusion. Overall, these retinal perfusion changes were noticed at 6 weeks and remained unaltered at 10 weeks.

Conclusions : These results indicate that diabetes causes significant delay and prolongation of retinal perfusion in mice, and that metformin treatment may inhibit such alterations.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×